Given that BCR-ABL interacts and activates SRC kinases, ID1 upregulation through BCR-ABL dependent and independent mechanisms is likely to have a key role in CML pathophysiology. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.